A

Annovis Bio
D

ANVS

2.91000
USD
0.06
(1.93%)
مغلق
حجم التداول
5,795
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
56,704,932
أصول ذات صلة
ALNY
ALNY
1.29
(0.39%)
329.01 USD
A
ASND
-1.020
(-0.61%)
167.490 USD
C
CRBP
0.18000
(2.00%)
9.17000 USD
E
EYPT
-0.005
(-0.05%)
10.480 USD
V
VKTX
0.960
(2.87%)
34.420 USD
المزيد
الأخبار المقالات

العنوان: Annovis Bio

القطاع: Healthcare
الصناعة: Biotechnology
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the companyconsists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.